Literature DB >> 24942777

Early netrin-1 expression impairs central nervous system remyelination.

Vanja Tepavčević1, Christophe Kerninon, Marie Stéphane Aigrot, Elodie Meppiel, Sabah Mozafari, Raphaelle Arnould-Laurent, Philippe Ravassard, Timothy E Kennedy, Brahim Nait-Oumesmar, Catherine Lubetzki.   

Abstract

OBJECTIVE: Chronically demyelinated multiple sclerosis (MS) lesions are frequently characterized by scarce undifferentiated oligodendrocyte progenitor cells (OPCs), suggesting the exhaustion of a local OPC pool followed by failure of recruitment and differentiation. Stimulating prompt OPC recruitment following demyelination could improve myelin repair by providing sufficient numbers of remyelinating cells during the repair-permissive period. Understanding mechanisms that determine this process may have important therapeutic implications. We therefore investigated the role of the guidance molecule netrin-1 in OPC recruitment and central nervous system (CNS) remyelination.
METHODS: Netrin-1 expression was analyzed immunohistochemically in different types of MS lesions and in the murine lysolecithin model of demyelination. The influence of netrin-1 on CNS remyelination was examined using gain and loss of function experiments.
RESULTS: We show that in MS lesions, astrocytes upregulate netrin-1 expression early during demyelination and netrin-1 receptors are expressed by OPCs. In contrast, in the efficiently repairing lysolecithin model of demyelination (astrocyte-free), netrin-1 expression is absent during early phases and detected concomitant with completion of OPC recruitment. In vitro migration assays demonstrated that netrin-1 is a chemorepellent for migrating adult OPCs. In mouse lesions, antibody-mediated disruption of netrin-1 function at the peak phase of recruitment increased OPC numbers. Conversely, lentiviral-mediated induction of netrin-1 expression prior to OPC recruitment reduced the number of cells recruited and impaired remyelination.
INTERPRETATION: Our findings support the conclusion that netrin-1 expression within demyelinating MS plaques blocks OPC recruitment, which with repeated demyelinating episodes contributes to permanent remyelination failure.
© 2014 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24942777     DOI: 10.1002/ana.24201

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  25 in total

1.  Netrin 1 regulates blood-brain barrier function and neuroinflammation.

Authors:  Cornelia Podjaski; Jorge I Alvarez; Lyne Bourbonniere; Sandra Larouche; Simone Terouz; Jenea M Bin; Marc-André Lécuyer; Olivia Saint-Laurent; Catherine Larochelle; Peter J Darlington; Nathalie Arbour; Jack P Antel; Timothy E Kennedy; Alexandre Prat
Journal:  Brain       Date:  2015-04-22       Impact factor: 13.501

2.  Truncated netrin-1 contributes to pathological vascular permeability in diabetic retinopathy.

Authors:  Khalil Miloudi; François Binet; Ariel Wilson; Agustin Cerani; Malika Oubaha; Catherine Menard; Sullivan Henriques; Gaelle Mawambo; Agnieszka Dejda; Phuong Trang Nguyen; Flavio A Rezende; Steve Bourgault; Timothy E Kennedy; Przemyslaw Sapieha
Journal:  J Clin Invest       Date:  2016-07-11       Impact factor: 14.808

Review 3.  The oligodendrocyte growth cone and its actin cytoskeleton: A fundamental element for progenitor cell migration and CNS myelination.

Authors:  Elizabeth J Thomason; Miguel Escalante; Donna J Osterhout; Babette Fuss
Journal:  Glia       Date:  2019-11-07       Impact factor: 7.452

4.  Mutations in the netrin-1 gene cause congenital mirror movements.

Authors:  Aurélie Méneret; Elizabeth A Franz; Oriane Trouillard; Thomas C Oliver; Yvrick Zagar; Stephen P Robertson; Quentin Welniarz; R J MacKinlay Gardner; Cécile Gallea; Myriam Srour; Christel Depienne; Christine L Jasoni; Caroline Dubacq; Florence Riant; Jean-Charles Lamy; Marie-Pierre Morel; Raphael Guérois; Jessica Andreani; Coralie Fouquet; Mohamed Doulazmi; Marie Vidailhet; Guy A Rouleau; Alexis Brice; Alain Chédotal; Isabelle Dusart; Emmanuel Roze; David Markie
Journal:  J Clin Invest       Date:  2017-09-25       Impact factor: 14.808

Review 5.  Remyelinating Pharmacotherapies in Multiple Sclerosis.

Authors:  Riley M Bove; Ari J Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 6.  Achievements and obstacles of remyelinating therapies in multiple sclerosis.

Authors:  Martin Stangel; Tanja Kuhlmann; Paul M Matthews; Trevor J Kilpatrick
Journal:  Nat Rev Neurol       Date:  2017-11-17       Impact factor: 42.937

7.  Age-Dependent Netrin-1 Signaling Regulates NG2+ Glial Cell Spatial Homeostasis in Normal Adult Gray Matter.

Authors:  Fikri Birey; Adan Aguirre
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

Review 8.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

Review 9.  Migratory potential of transplanted glial progenitors as critical factor for successful translation of glia replacement therapy: The gap between mice and men.

Authors:  Rohit K Srivastava; Jeff W M Bulte; Piotr Walczak; Miroslaw Janowski
Journal:  Glia       Date:  2017-12-20       Impact factor: 7.452

Review 10.  Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.

Authors:  Mahsa Motavaf; Majid Sadeghizadeh; Mohammad Javan
Journal:  Cell Mol Neurobiol       Date:  2017-02-21       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.